23andMe SPAC Presentation Deck

Genetic Data Fuels Massive Market Opportunities LCHE TOID CD HEL ● AD P 10M+ genotyped customers and growing D McKinsey, "Telehealth: a quarter-trillion-dollar post-Covid-19 reality?" (2020). 2 EvaluatePharma, "World Preview 2020, Outlook to 2026" (2020). L I BEREND D U.S. Telehealth TAM $250B¹ Global Prescription Drug TAM $825B² Pharma R&D TAM $190B² 23andMe Confidential and Proprietary Information 35

View entire presentation